| /report/000095017025015361-moxie-dwight-2025-02-04 |
Revance Therapeutics, Inc. |
04 Feb 2025 |
4 |
-$174,525 |
4 |
CLO & GC |
06 Feb 2025, 15:58 |
| /report/000095017025014823-moxie-dwight-2025-02-03 |
Revance Therapeutics, Inc. |
03 Feb 2025 |
1 |
$0 |
4 |
CLO & GC |
05 Feb 2025, 19:53 |
| /report/000147929024000067-moxie-dwight-2024-03-15 |
Revance Therapeutics, Inc. |
15 Mar 2024 |
2 |
-$58,313 |
4 |
CLO & GC |
19 Mar 2024, 18:44 |
| /report/000147929024000053-moxie-dwight-2024-02-29 |
Revance Therapeutics, Inc. |
29 Feb 2024 |
1 |
$0 |
4 |
CLO & GC |
04 Mar 2024, 17:33 |
| /report/000147929024000016-moxie-dwight-2024-01-31 |
Revance Therapeutics, Inc. |
31 Jan 2024 |
2 |
$0 |
4 |
SVP, GC & Secretary |
02 Feb 2024, 16:48 |
| /report/000147929023000102-moxie-dwight-2023-09-05 |
Revance Therapeutics, Inc. |
05 Sep 2023 |
2 |
-$612,624 |
4 |
SVP, GC & Secretary |
07 Sep 2023, 17:37 |
| /report/000147929023000098-moxie-dwight-2023-08-11 |
Revance Therapeutics, Inc. |
11 Aug 2023 |
2 |
-$181,385 |
4 |
SVP, GC & Secretary |
15 Aug 2023, 16:15 |
| /report/000147929023000040-moxie-dwight-2023-03-15 |
Revance Therapeutics, Inc. |
15 Mar 2023 |
1 |
-$224,664 |
4 |
SVP, GC & Secretary |
17 Mar 2023, 15:21 |
| /report/000147929023000014-moxie-dwight-2023-01-31 |
Revance Therapeutics, Inc. |
31 Jan 2023 |
1 |
$0 |
4 |
SVP, GC & Secretary |
02 Feb 2023, 20:37 |
| /report/000147929023000037-moxie-dwight-2022-09-22 |
Revance Therapeutics, Inc. |
22 Sep 2022 |
2 |
-$584,220 |
4 |
SVP, GC & Secretary |
09 Mar 2023, 20:46 |
| /report/000147929022000086-moxie-dwight-2022-09-14 |
Revance Therapeutics, Inc. |
14 Sep 2022 |
1 |
-$297,798 |
4 |
SVP, GC & Secretary |
16 Sep 2022, 16:55 |
| /report/000120919122019721-moxie-dwight-2022-03-15 |
Revance Therapeutics, Inc. |
15 Mar 2022 |
2 |
-$80,687 |
4 |
SVP, GC & Secretary |
17 Mar 2022, 17:52 |
| /report/000147929023000076-moxie-dwight-2022-02-02 |
Revance Therapeutics, Inc. |
02 Feb 2022 |
2 |
-$739,338 |
4 |
SVP, GC & Secretary |
16 May 2023, 20:29 |
| /report/000147929022000016-moxie-dwight-2022-02-02 |
Revance Therapeutics, Inc. |
02 Feb 2022 |
1 |
$0 |
4 |
SVP, GC & Secretary |
04 Feb 2022, 19:36 |
| /report/000147929021000154-moxie-dwight-2021-09-27 |
Revance Therapeutics, Inc. |
27 Sep 2021 |
1 |
-$50,250 |
4 |
SVP, GC & Secretary |
28 Sep 2021, 21:23 |